Literature DB >> 20680419

Death anxiety and symbolic immortality in relatives at risk for familial amyloid polyneuropathy type I (FAP I, ATTR V30M).

Paula I Santos1, Eurico Figueiredo, Inês Gomes, Jorge Sequeiros.   

Abstract

This study is an investigation of the impact of familial amyloid polyneuropathy type I (FAP I, ATTR V30M) on death anxiety and symbolic immortality. Templer and Drolet's scales were administered to 524 individuals: (1) 84 relatives at risk, (2) 92 relatives not at risk for FAP I; and (3) a control group (n = 348) with no known hereditary disease in their families. At-risk relatives had, on average, a higher score for death anxiety and a lower score for symbolic immortality, than either those not-at-risk or controls. There were no significant differences in scores on either measure for those not-at-risk versus controls. Being at risk increases death anxiety and threatens the sense of symbolic immortality and psychosocial wellbeing. This may be true for other serious hereditary disorders as well. Genetic counsellors should become familiar with these concepts, feel comfortable initiating discussions about death with their patients, and be able to identify and reinforce their patients' and family members' sense of symbolic immortality.

Entities:  

Mesh:

Year:  2010        PMID: 20680419     DOI: 10.1007/s10897-010-9311-3

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  34 in total

Review 1.  The future of genetic counselling: an international perspective.

Authors:  B Bowles Biesecker; T M Marteau
Journal:  Nat Genet       Date:  1999-06       Impact factor: 38.330

2.  ON DEATH AND DEATH SYMBOLISM: THE HIROSHIMA DISASTER.

Authors:  R J LIFTON
Journal:  Psychiatry       Date:  1964-08       Impact factor: 2.458

3.  Predictive genetic testing and beyond: a theory of engagement.

Authors:  Marion McAllister
Journal:  J Health Psychol       Date:  2002-09

4.  Death anxiety as related to depression and health of retired persons.

Authors:  D I Templer
Journal:  J Gerontol       Date:  1971-10

5.  Death anxiety in religiously very involved persons.

Authors:  D I Templer
Journal:  Psychol Rep       Date:  1972-10

6.  Family members' experience of familial amyloidotic polyneuropathy disease--an infernal struggle and a fact of life.

Authors:  E Jonsén; E Athlin; O B Suhr
Journal:  J Adv Nurs       Date:  2000-02       Impact factor: 3.187

Review 7.  Psychological consequences of predictive genetic testing: a systematic review.

Authors:  M Broadstock; S Michie; T Marteau
Journal:  Eur J Hum Genet       Date:  2000-10       Impact factor: 4.246

8.  What do death anxiety scales measure?

Authors:  David Lester
Journal:  Psychol Rep       Date:  2007-12

9.  Neurofibromatosis type 1 (NF1): knowledge, experience, and reproductive decisions of affected patients and families.

Authors:  C M Benjamin; A Colley; D Donnai; H Kingston; R Harris; L Kerzin-Storrar
Journal:  J Med Genet       Date:  1993-07       Impact factor: 6.318

10.  Psychosocial needs of family members of liver transplant patients.

Authors:  C R Benning; A Smith
Journal:  Clin Nurse Spec       Date:  1994-09       Impact factor: 1.067

View more
  2 in total

1.  Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy.

Authors:  Lorenza Magliano; Laura Obici; Claudia Sforzini; Anna Mazzeo; Massimo Russo; Francesco Cappelli; Silvia Fenu; Marco Luigetti; Matteo Tagliapietra; Chiara Gemelli; Luca Leonardi; Stefano Tozza; Luca Guglielmo Pradotto; Giulia Citarelli; Alessandro Mauro; Fiore Manganelli; Giovanni Antonini; Marina Grandis; Gian Maria Fabrizi; Mario Sabatelli; Davide Pareyson; Federico Perfetto; Giampaolo Merlini; Giuseppe Vita
Journal:  Orphanet J Rare Dis       Date:  2021-04-07       Impact factor: 4.123

2.  Nurses' Death Anxiety and Ageism towards Older Adults Amid the COVID-19 Pandemic: The Moderating Role of Symbolic Immortality.

Authors:  Mohammad Rababa; Shatha Al-Sabbah; Dania Bani-Hamad
Journal:  Geriatrics (Basel)       Date:  2022-06-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.